Bausch Health Cos., Inc. (BHC)
6.32
+0.02
(+0.32%)
USD |
NYSE |
Aug 28, 13:48
Bausch Health Cos. Price to Book Value
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| March 30, 2021 | 20.62 |
| March 29, 2021 | 20.39 |
| March 26, 2021 | 20.59 |
| March 25, 2021 | 20.66 |
| March 24, 2021 | 20.40 |
| March 23, 2021 | 21.03 |
| March 22, 2021 | 21.90 |
| March 19, 2021 | 21.92 |
| March 18, 2021 | 21.82 |
| March 17, 2021 | 22.13 |
| March 16, 2021 | 22.18 |
| March 15, 2021 | 22.45 |
| March 12, 2021 | 22.15 |
| March 11, 2021 | 22.84 |
| March 10, 2021 | 21.80 |
| March 09, 2021 | 22.54 |
| March 08, 2021 | 21.98 |
| March 05, 2021 | 21.90 |
| March 04, 2021 | 21.19 |
| March 03, 2021 | 21.63 |
| March 02, 2021 | 21.44 |
| March 01, 2021 | 21.09 |
| February 26, 2021 | 20.87 |
| February 25, 2021 | 20.78 |
| February 24, 2021 | 20.63 |
| Date | Value |
|---|---|
| February 23, 2021 | 20.97 |
| February 22, 2021 | 21.01 |
| February 19, 2021 | 21.21 |
| February 18, 2021 | 20.98 |
| February 17, 2021 | 21.28 |
| February 16, 2021 | 20.81 |
| February 12, 2021 | 20.75 |
| February 11, 2021 | 20.00 |
| February 10, 2021 | 19.65 |
| February 09, 2021 | 19.40 |
| February 08, 2021 | 19.17 |
| February 05, 2021 | 18.69 |
| February 04, 2021 | 18.36 |
| February 03, 2021 | 18.14 |
| February 02, 2021 | 17.93 |
| February 01, 2021 | 17.16 |
| January 29, 2021 | 16.94 |
| January 28, 2021 | 17.07 |
| January 27, 2021 | 16.47 |
| January 26, 2021 | 17.57 |
| January 25, 2021 | 17.94 |
| January 22, 2021 | 17.71 |
| January 21, 2021 | 17.72 |
| January 20, 2021 | 17.94 |
| January 19, 2021 | 18.28 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| InMed Pharmaceuticals, Inc. | 0.6781 |
| NervGen Pharma Corp. | 19.92 |
| Milestone Pharmaceuticals, Inc. | 7.859 |
| Clearmind Medicine, Inc. | 0.1614 |
| Lexaria Bioscience Corp. | 3.732 |
Price to Book Value Related Metrics
| PS Ratio | 0.2179 |
| Price to Free Cash Flow | 1.717 |
| Price | 6.32 |
| Earnings Yield | -46.84% |
| Market Cap | 2.363B |
| Operating PE Ratio | 0.8657 |
| Normalized PE Ratio | 11.61 |